(Fox News) A newly published study from researchers at Mount Sinai hospital system in New York shows the “vast majority” of patients with mild-to-moderate COVID-19 symptoms have antibodies for at least three months.
The study, which has not yet been peer-reviewed, was based on nearly 20,000 individuals with the virus.
“…We report that the vast majority of infected individuals with mild-to-moderate COVID-19 experience robust IgG antibody responses against the viral spike protein, based on a dataset of 19,860 individuals screened at Mount Sinai Health System in New York City,” researchers wrote in the study’s abstract.